AKYNZEO 300 mg/1
Netupitant and Palonosetron · CAPSULE · Helsinn Therapeutics (U.S.), Inc.
AKYNZEO is a capsule containing netupitant and palonosetron at 300 mg/1, taken oral. Manufactured by Helsinn Therapeutics (U.S.), Inc..
Key Facts
- Brand Name
- AKYNZEO
- Generic Name
- Netupitant and Palonosetron
- NDC Code (Product)
69639-101- Manufacturer
- Helsinn Therapeutics (U.S.), Inc.
- Strength
- 300 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA205718
- Drug Class
- Serotonin-3 Receptor Antagonist [EPC]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- Marketing Start
- 10/13/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is AKYNZEO used for?
AKYNZEO contains Netupitant and Palonosetron. It is a capsule taken oral. Consult your doctor for specific uses.
Is AKYNZEO a controlled substance?
AKYNZEO is not classified as a controlled substance by the DEA.
What is the generic name for AKYNZEO?
The generic name for AKYNZEO is Netupitant and Palonosetron. There are no other listed brand versions of Netupitant and Palonosetron.
What is the NDC code for AKYNZEO 300 mg/1?
The NDC (National Drug Code) for AKYNZEO 300 mg/1 is 69639-101, listed by Helsinn Therapeutics (U.S.), Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)